Family Communication and Support in the Pediatric Intensive Care Unit

November 19, 2015 updated by: Ross Hays

Improving Family Outcomes With a Communication Intervention in the Pediatric ICU

This project is evaluating the effect of a standardized communication intervention in the pediatric intensive care unit (PICU) on long-term distress of family members of children in the PICU for 5 days or longer. The study hypothesis is that intervention families will have lower (better) acute stress disorder scores when their child is discharged from the PICU and lower (better) post-traumatic stress disorder scores at 3-month follow-up, as compared to the control group families. The investigators will recruit 220 families (110 in each of the control and intervention groups). Families who are randomized to the intervention group will receive routine visits from members of the PACT (palliative care) team at least three times/week to address psychosocial needs, keep families informed about their child's health status, and offer emotional and instrumental support and resources. Families in the control group will receive usual care in the PICU. The intervention will end whenever the child is discharged from the PICU, which usually happens within 3 weeks of enrollment. The investigators will assess family outcomes at discharge from the PICU and 90 days after study enrollment. The investigators will conduct two additional activities to learn more about the processes of care for those in both the intervention and control groups. First, during the intervention, the investigators will recruit 30 families (15 in each group) and ask permission to audio-record the family care conferences to assess communication styles and gain greater insight into the differences in practice with or without the participation of the intervention team. The investigators will obtain additional consent from participants in these family conferences who are not otherwise enrolled in the study. Second, after completion of the 3-month follow-up interview, a sub-sample of a different 30 families (again, 15 in each group) will be invited to participate in qualitative interviews to debrief about their experience in the study and the intervention (for those in that group). This will be a one-time interview scheduled within 60 days of recruitment for this part of the project.

Study Overview

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98105
        • Seattle Childrens Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 18 years or older
  • actively involved in the life of the patient receiving care; and
  • functionally fluent in English or Spanish.

Exclusion Criteria:

  • discharge plan in place for patient before day 4
  • previously received palliative care
  • patient placed on extracorporeal membrane oxygenation (ECMO)
  • no prior admission to ICU for same hospitalization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual care
No treatment for this group
usual hospital care, not assigned to palliative care team
Experimental: Assigned to palliative care team
The intervention group will be assigned to a palliative care team member that will facilitate communication and meetings between families and the medical team
Communication and Support through the palliative care team assigned to intervention participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post Traumatic Stress Disorder
Time Frame: 90 days after baseline
PTSD will be measures using the Post Traumatic Stress Disorder (PCL-C) scale.
90 days after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acute Stress Disorder
Time Frame: Baseline, and up to 90 days after
Will be measured using the Acute Stress Disorder Scale
Baseline, and up to 90 days after
Communication Satisfaction
Time Frame: Baseline, and up to 90 days after
Questions will be asked about family satisfaction with provider communication.
Baseline, and up to 90 days after
Conflict
Time Frame: Baseline and up to 90 days after
Questions will be asked about conflict with providers.
Baseline and up to 90 days after

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental Health Symptoms
Time Frame: Baseline and up to 90 days after
Will be measured with the PHQ-9 (Depression) and GAD-7 (Anxiety) scales.
Baseline and up to 90 days after
Family Relationship
Time Frame: Baseline and up to 90 days after
Will be measured using the Family relationship index
Baseline and up to 90 days after
Social Support
Time Frame: Baseline and up to 90 days after
Will be measured using the Perceived Social Support scale.
Baseline and up to 90 days after

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Ross Hays, MD, Seattle Childrens Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

May 14, 2014

First Submitted That Met QC Criteria

May 19, 2014

First Posted (Estimate)

May 22, 2014

Study Record Updates

Last Update Posted (Estimate)

November 20, 2015

Last Update Submitted That Met QC Criteria

November 19, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 1RO1NRO11179

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Reducing Post Traumatic Stress

Clinical Trials on Usual Care

3
Subscribe